HC Wainwright & Co. Reiterates Neutral on Lipocine, Announces $4 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 42.6%

Neg 0% Neu 42.6% Pos 0%

HC Wainwright & Co. analyst Yi Chen reiterates Lipocine (NASDAQ:LPCN) with a Neutral and announces $4 price target.

Comments

No comments yet. Be the first!